Natera Stock-Based Compensation 2014-2025 | NTRA

Natera annual/quarterly stock-based compensation history and growth rate from 2014 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • Natera stock-based compensation for the quarter ending March 31, 2025 was $0.078B, a 20.76% increase year-over-year.
  • Natera stock-based compensation for the twelve months ending March 31, 2025 was $0.687B, a 42.03% increase year-over-year.
  • Natera annual stock-based compensation for 2024 was $0.274B, a 43.07% increase from 2023.
  • Natera annual stock-based compensation for 2023 was $0.192B, a 25.87% increase from 2022.
  • Natera annual stock-based compensation for 2022 was $0.152B, a 32.26% increase from 2021.
Natera Annual Stock-Based Compensation
(Millions of US $)
2024 $274
2023 $192
2022 $152
2021 $115
2020 $50
2019 $29
2018 $14
2017 $11
2016 $11
2015 $7
2014 $5
2013 $2
Sector Industry Market Cap Revenue
Medical Medical Services $21.906B $1.697B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.605B 27.50
CVS Health (CVS) United States $81.948B 10.19
Elevance Health (ELV) United States $76.969B 9.93
Cencora (COR) United States $57.219B 19.91
DiDi Global (DIDIY) China $24.191B 25.70
Labcorp Holdings (LH) United States $20.893B 16.95
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.687B 0.00
CochLear (CHEOY) Australia $12.827B 0.00
Solventum (SOLV) United States $12.768B 13.52
ICON (ICLR) Ireland $12.156B 11.30
Revvity (RVTY) United States $11.964B 20.59
Viatris (VTRS) United States $10.704B 3.68
Medpace Holdings (MEDP) United States $9.298B 24.69
Avantor (AVTR) United States $9.254B 13.45
Sonic Healthcare (SKHHY) Australia $8.886B 0.00
HealthEquity (HQY) United States $8.174B 35.80
Charles River Laboratories (CRL) United States $7.829B 15.34
Caris Life Sciences,�Inc (CAI) United States $6.744B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.911B 28.92
BrightSpring Health Services (BTSG) United States $3.571B 32.76
Sotera Health (SHC) United States $3.349B 19.03
Surgery Partners (SGRY) United States $2.825B 36.73
Alignment Healthcare (ALHC) United States $2.645B 0.00
Organon (OGN) United States $2.584B 2.75
Concentras Parent (CON) United States $2.551B 14.74
GeneDx Holdings (WGS) United States $2.356B 90.72
Ardent Health (ARDT) United States $2.027B 8.64
Progyny (PGNY) United States $1.990B 43.79
PACS (PACS) United States $1.932B 0.00
Premier (PINC) United States $1.736B 13.18
GoodRx Holdings (GDRX) United States $1.695B 33.89
Teladoc Health (TDOC) United States $1.460B 0.00
Establishment Labs Holdings (ESTA) $1.298B 0.00
Pediatrix Medical (MD) United States $1.127B 8.58
CareDx (CDNA) United States $1.121B 17.50
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.923B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.810B 7.58
Nutex Health (NUTX) United States $0.637B 9.64
Embecta (EMBC) United States $0.612B 4.12
InnovAge Holding (INNV) United States $0.559B 0.00
SBC Medicals (SBC) United States $0.523B 0.00
LifeMD (LFMD) United States $0.512B 0.00
Sonida Senior Living (SNDA) United States $0.482B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
Omada Health (OMDA) $0.455B 0.00
So-Young (SY) China $0.390B 0.00
Enhabit (EHAB) United States $0.357B 29.38
COMPASS Pathways (CMPS) United Kingdom $0.344B 0.00
Performant Healthcare (PHLT) United States $0.321B 0.00
Oncology Institute (TOI) United States $0.279B 0.00
Beauty Health (SKIN) United States $0.241B 0.00
DocGo (DCGO) United States $0.152B 24.83
Pheton Holdings (PTHL) China $0.138B 0.00
Sera Prognostics (SERA) United States $0.107B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
KindlyMD (NAKA) United States $0.074B 0.00
IceCure Medical (ICCM) Israel $0.061B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.046B 0.00
Biodesix (BDSX) United States $0.045B 0.00
Basel Medical Group (BMGL) Singapore $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
OSR Holdings (OSRH) United States $0.023B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00